Inflammation and Coagulation: Linked Processes Potentially Regulated Through a Common Pathway Mediated by Protein C

References
1 Mann KG, Nesheim ME, Church WR, Haley P, Krishnaswamy S. Surface-dependent reactions of the vitamin K-dependent enzyme complexes. Blood 1990; 76: 1-16
2 Taylor Jr FB. Studies of the natural history and mechanism of the primate (baboon) response to E. coli. . In: Immunopharmacology and pathophysiology of lipopolysaccharides, Bacterial Endotoxic Lipopolysaccharides Series. ( DC Morrison, JL Ryan. eds. ), CRC Press: Vol. 2, in press
3 Hinshaw LB, Chang ACK, Beller-Todd BK, Archer LT, Taylor Jr FB. Extracorporeal perfusion without exogenous anticoagulation: Its protective role in endotoxin shock. Circ. Shock 1982; 9: 281-295
4 Fletcher JR, McKee AE, Herman CM. Membrane oxygenation in baboons without anticoagulants. J. Surg. Res. 1977; 22: 273-280
5 Esmon CT, Owen WG. Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. Proc. Natl. Acad. Sci. (USA) 1981; 78: 2249-2252
6 Esmon CT. The roles of protein C and thrombomodulin in the regulation of blood coagulation. J. Biol. Chem. 1989; 264: 4743-4746
7 Comp PC, Jacocks RM, Ferrell GL, Esmon CT. Activation of protein C in vivo. J. Clin. Invest. 1982; 70: 127-134
8 Hyde E, Wetmore R, Gurewich V. Isolation and characterization of an in vivo thrombin-induced anticoagulant activity. Scand. J. Haemat. 1974; 13: 121-128
9 Taylor Jr FB, Chang A, Hinshaw LB, Esmon CT, Archer LT, Beller BK. A model for thrombin protection against endotoxin. Thromb. Res. 1984; 36: 177-185
10 Taylor Jr FB, Chang A, Esmon CT, D'Angelo A, Vigano-D'Angelo S, Blick KE. Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon. J. Clin. Invest. 1987; 79: 918-925
11 Coalson JJ, Benjamin B, Archer LT, Beller B, Gilliam CL, Taylor FB, Hinshaw LB. Prolonged shock in the baboon subjected to infusion of E. coli endotoxin. Circ. Shock 1978; 5: 423-437
12 Reilly CF, Fritze L, Rosenberg RD. Antiproliferative effects of heparin on vascular smooth muscle cells are reversed by epidermal growth factor. J. Cell. Physiol. 1987; 131: 149-157
13 Krishnaswamy S, Jones KC, Mann KG. Prothrombinase complex assembly: Kinetic mechanism of enzyme assembly on phospholipid vesicles. J. Biol. Chem. 1988; 263: 3823-3834
14 Taylor Jr FB, Chang AK, Mather T, Blick K, Catlett R, Esmon CT. DEGR-Factor Xa blocks disseminated intravascular coagulation initiated by E. coli without preventing shock or organ damage. Blood 1991; in press.
15 Warr TA, Rao VM, Rapaport SI. Disseminated intravascular coagulation in rabbits induced by administration of endotoxin or tissue factor: Effect of anti-tissue factor antibodies and measurement of plasma extrinsic pathway inhibitor activity. Blood 1990; 75: 1481-1489
16 Walker FJ. Regulation of activated protein C by a new protein. J. Biol. Chem. 1980; 255: 5521-5524
17 Comp PC, Nixon RR, Cooper MR, Esmon CT. Familial protein S deficiency is associated with recurrent thrombosis. J. Clin. Invest. 1984; 74: 2082-2088
18 Dahlback B. Inhibition of protein Ca cofactor function of human and bovine protein S by C4b-binding protein. J. Biol. Chem. 1986; 261: 12022-12027
19 Craddock PR. Complement-mediated intravascular leukostasis and endothelial cell injury. In: Pathobiology of the Endothelial Cell. ( ed. Nossel H. ) Academic Press, Inc., New York,: 1982. pp 369-386
20 D'Angelo A, Vigano-D'Angelo S, Esmon CT, Comp PC. Acquired deficiencies of protein S: Protein S activity during oral anticoagulation, in liver disease, and in disseminated intravascular coagulation. J. Clin. Invest. 1988; 81: 1445-1454
21 Keeling DM, Campbell SJ, Mackie IJ, Machin SJ, Isenberg DA. Total and free protein S in systemic lupus erythematosus. Thromb. Res. 1990; 60: 237-240
22 Beutler B, Milsark IW, Cerami AC. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 1985; 229: 869-871
23 Taylor Jr FB, Esmon CT, Chang A. Primate model of deep vein thrombosis induced by inflammatory mediators.. Circulation 1990; 82 (III) 770 (abstr. #3060)
24 Wakefield TW, Wrobleski SK, Sarpa MS, Taylor Jr FB, Esmon CT, Greenfield LJ. Deep venous thrombosis in the baboon generated through protein C inhibition.. (Manuscript submitted)
25 Crawford MH, Grover FL, Kolb WP, McMahan A, O'Rourke RA, McManus LM, Pinckard RN. Complement and neutrophil activation in the pathogenesis of ischemic myocardial injury. Circulation 1988; 78: 1449-1458
26 Hærem JW. Platelet aggregates in intramyocardial vessels of patients dying suddenly and unexpectedly of coronary artery disease. Atherosclerosis 1972; 15: 199-213
27 Maury CPJ, Teppo AM. Circulating tumour necrosis factor (cachectin) in myocardial infarction. J. Int. Med. 1989; 225: 333-336
28 Snow TR, Deal MT, Dickey DT, Esmon CT. Protein C activation following coronary artery occlusion in the in-situ porcine heart. Circulation 1991; in press.
29 Conway EM, Rosenberg RD. Tumor necrosis factor suppresses transcription of the thrombomodulin gene in endothelial cells. Mol. Cell Biol. 1988; 8: 5588-5592
30 Moore K, Esmon CT, Esmon NL. Tumor necrosis factor leads to the internalization and degradation of thrombomodulin from the surface of bovine aortic endothelial cells in culture. Blood 1989; 73: 159-165
31 Key NS, Vercellotti GM, Esmon NL, Esmon CT, Jacob HS. Neutrophils enhance the procoagulant effects of tumor necrosis factor on endothelium by accelerating thrombomodulin loss: Role in endotoxin shock.. Clin. Res. 1989; 37: 601A (abstr.)
32 Gimbrone Jr MA. Vascular endothelium: Nature's blood container. In: Vascular Endothelium in Hemostasis and Thrombosis, Contemporary Issue in Haemostasis and Thrombosis. ( Gimbrone MA. , ed.) Churchill Livingstone, New York,: 1986. Vol. 2, pp. 01-13